- New
Tesamorelin 20 mg · Lyophilised vial
GHRH analog targeting visceral fat and GH output.
GH release with a strong appetite kick.
GH release with a strong appetite kick. Active: GHRP-6. Strength: 10 mg. Form: Lyophilised vial. Route: Subcutaneous. Class: GH secretagogue. Supplied under the Hexal-OZ line. Priced in AUD; paid in crypto via BTCPay (XMR preferred, BTC secondary).
Data sheet
GHRH analog targeting visceral fat and GH output.
Anti-inflammatory and gut-health tripeptide.
Mitochondrial peptide for metabolism and endurance.
Mitochondria-targeted recovery and longevity peptide.
Stimulates the natural LH/FSH hormone axis.
Pre-filled retatrutide pen — GLP-1/GIP/glucagon.
191-aa recombinant growth hormone. Cold-chain kit.
Cellular energy and longevity coenzyme.
High-strength retatrutide vial for extended titration.
Telomerase and longevity research peptide.
Hair and follicle copper peptide. Often topical.
The go-to GH-pulse stack in one vial.
Systemic recovery and flexibility. Pairs with BPC-157.
GLP-1/GIP dual agonist for appetite and glucose.